Stock Research: Personalis

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Personalis

NasdaqGM:PSNL US71535D1063
36
  • Value
    55
  • Growth
    49
  • Safety
    Safety
    45
  • Combined
    48
  • Sentiment
    40
  • 360° View
    360° View
    36
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and analytics to support personalized cancer vaccines and immunotherapies. Its main businesses include genomic sequencing and analytics, with products like NeXT Personal, ImmunoID NeXT, NeXT Personal Dx, NeXT Dx, whole exome sequencing (WES), and whole genome sequencing (WGS). The company's tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and personalized cancer therapies. In the last fiscal year, the company had a market cap of $563 million, profits of $27 million, revenue of $85 million, and 229 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 36 (better than 36% compared with alternatives), overall professional sentiment and financial characteristics for the stock Personalis are below the industry average. The 360° View is based on consolidating four consolidated indicators, with three out of four metrics below average for Personalis. The only rank that is above average is the consolidated Safety Rank at 55, which means that the company has a financing structure that is safer than those of 55% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the Value, Growth and Sentiment Ranks are all below average. The consolidated Value Rank has a less desirable rank of 45, which means that the share price of Personalis is on the high side compared with typical size in indicators such as revenues, profits, and invested capital. The consolidated Growth Rank also has a low rank of 49, which implies that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. Finally, the consolidated Sentiment Rank is also low at a rank of 40, which means that professional investors are more pessimistic about the stock than for 60% of alternative investment opportunities. While Safety is strong, it’s not the most critical indicator, so we suggest proceeding with caution if you are considering this stock. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
45 28 85 71
Growth
49 55 39 7
Safety
Safety
55 26 79 90
Sentiment
40 70 64 29
360° View
360° View
36 41 91 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
76 71 67 64
Opinions Change
15 36 50 50
Pro Holdings
n/a 51 41 19
Market Pulse
75 75 51 38
Sentiment
40 70 64 29
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
45 28 85 71
Growth
49 55 39 7
Safety Safety
55 26 79 90
Combined
48 14 82 56
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
88 88 88 30
Price vs. Earnings (P/E)
44 35 91 38
Price vs. Book (P/B)
55 43 88 94
Dividend Yield
1 1 1 1
Value
45 28 85 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
89 14 14 8
Profit Growth
37 73 56 26
Capital Growth
33 28 71 87
Stock Returns
25 100 35 7
Growth
49 55 39 7
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
69 62 68 100
Refinancing
73 47 89 99
Liquidity
4 1 7 1
Safety Safety
55 26 79 90

Similar Stocks

Discover high‑ranked alternatives to Personalis and broaden your portfolio horizons.

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.